drugset / Trial / NCT07325240

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

NCT07325240

Phase 4 Recruiting 30 enrolled Mayo Clinic Alcon Research · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effect on 24-hour IOP reduction of netarsudil-latanoprost fixed combination in one eye compared to latanoprost alone in the contralateral eye, dosed daily, 1 drop at night (QD, PM) in adult subjects, at least 18 years of age, with open angle glaucoma (OAG) or ocular hypertension (OHT).

Timeline

Start
2025-11-21
Primary completion
2027-07
Completion
2027-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Other
Subject netarsudil-latanoprost Unknown 0.005 % Other
Subject netarsudil-latanoprost Unknown 0.02 % Other